Simple Summary Magnetic resonance (MR) imaging had limited clinical indications in
patients with thoracic malignancies in the last a few decades. However, technical advances …

Magn Reson Imaging Clin N Am 23 (2015) 231–244 http://dx. doi. org/10.1016/j. mric.
2015.01. 012 1064-9689/15/$–see front matter© 2015 Elsevier Inc. All rights reserved. mri …

Since the publication of the Radiologic Diagnostic Oncology Group Report in 1991, the
clinical application of pulmonary magnetic resonance imaging (MRI) in patients with lung …

Lung cancer is the leading cause of cancer-related deaths worldwide, and imaging
techniques such as chest radiography, computed tomography (CT), positron emission …

Lung cancer is the leading cause of cancer death worldwide. Prognosis and treatment
outcomes are known to be related to the disease stage at the time of diagnosis. Therefore …

Compared to computed tomography (CT), magnetic resonance imaging (MRI) only plays a
minor role for the imaging of lung cancer. Among the reasons are technical limitations, such …

Since MR imaging was introduced for the assessment of thoracic and lung diseases, various
limitations, mostly related to the relatively low proton density of lung parenchyma, the …

Since thoracic MR imaging was first used in a clinical setting, it has been suggested that MR
imaging has limited clinical utility for thoracic diseases, especially lung diseases, in …

Since the clinical introduction of magnetic resonance imaging (MRI), the chest has been one
of its most challenging applications, and since the 1980s many physicists and radiologists …

Despite magnetic resonance imaging (MRI) being a mainstay in the oncologic care for many
disease sites, it has not routinely been used in early lung cancer diagnosis, staging, and …